BASF SE have entered a strategic partnership to bring a new choline chloride product to the feed industry in India and the rest of South Asia

MUMBAI: BASF SE, one of the leading companies in the animal nutrition industry through BASF South East Asia Pte Ltd. and Vital Therapeutics Pvt. Ltd, a leading manufacturer of vitamin premixes and veterinary formulations in India, have entered a strategic partnership to bring a new choline chloride product to the feed industry in India and the rest of South Asia.

The two companies will provide a range of choline chloride powder formulations to address specific market needs. Vital Therapeutics will launch the new choline chloride products at Poultry India Expo, held from November 22 to 24, in Hyderabad, India.

A sufficient supply of choline, important for building lecithin, acetylcholine and ceramides, contributes to a vital and productive flock. Animals can produce certain amounts of choline themselves, but it does not suffice to meet their own demand. Therefore, it is beneficial to add choline to feed.

The new choline chloride powder feed supplement comes in two formulations: a 60% corn cob-based formulation for application in poultry and dairy; and a 50% silica-based formulation for aquaculture. The new products will be marketed as “Vitachol 50” and “Vitachol 60” by Vital Therapeutics, and co-branded with BASF.

“This strategic alliance is the beginning of a new level of cooperation between BASF and Vital Therapeutics”, said Venugopal Setty, Managing Director, Vital Therapeutics Pvt. Ltd.

“This partnership between BASF and Vital Therapeutics has opened up a new market segment for choline chloride powder formulations, while offering the premium product to our customers at competitive price levels to meet their expectations”, he added.